Nextmune is owned by Fidelio, Premune (part of Serendipity sphere), board, management and previous owners.
The owners are fully aligned in their vision to create a next-generation specialty pharma company for companion animal health. With owners characterized by stability and flexibility, we can focus on long-term value creation instead of short-term profit maximization. Together, we share a vision for creating a world-class, sustainable business for generations to come.
Fidelio is a Swedish investment company that primarily invests in non-public companies in Northern Europe. The firm’s aim is to be an active owner that works closely together with management to drive growth and create healthy and strong businesses.
Premune (supported by Serendipity group)
Premune is a Swedish company dedicated to pet wellbeing. In addition to representing ownership in Nextmune, the company commercializes premier nutraceuticals. The company is part of the Serendipity sphere.
Board, management and previous owners
At around the foundation of Nextmune, Board and management invested in the company driven by the passion for building a next-generation specialty pharma company for better companion animal health. In addition, previous business owners who have found a new home in Nextmune have also re-invested a significant part of the proceeds into the company.